CN Patent

CN104688702A — 药物组合物

Assigned to Vifor International AG · Expires 2015-06-10 · 11y expired

What this patent protects

包含高载量羟基氧化铁的口服给药的药物组合物，尤其是以将直接吞咽或能够在口腔中崩解的经口传递系统给药。

USPTO Abstract

包含高载量羟基氧化铁的口服给药的药物组合物，尤其是以将直接吞咽或能够在口腔中崩解的经口传递系统给药。

Drugs covered by this patent

Patent Metadata

Patent number
CN104688702A
Jurisdiction
CN
Classification
—
Expires
2015-06-10
Drug substance claim
No
Drug product claim
No
Assignee
Vifor International AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.